chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vision went very blurry/could not see anything in front; Splotchy almost. Black and white; Felt dizzy; Right ear was affected, underwater like; Blood pressure 79/50 and again 70/48/ Which is very low for me; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 05Apr2021 at 10:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic cough due to GERD (gastroesophageal reflux disease)/silent reflux (currently under Dr's care for that), GERD and COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and gabapentin (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. The patient previously received Z-PACK (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm left on 09Mar2021 at 09:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 09:30, the morning after the shot the patient was sitting in bed, and her Vision went very blurry/could not see anything in front. Splotchy almost. Black and white. The patient felt dizzy too. The patient right ear was affected, underwater like. The patient thought it lasted about 2 minutes then passed. That happened two more times. The patient checked the blood pressure (BP) shortly after, and it was 79/50 (unspecified units) and again 70/48 (unspecified units). Which was very low for the patient. The patient had just been to the doctor the day before and BP was excellent. The patient had done nothing out of the ordinary for morning routine. It happened 3 times and then it never happened again. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vision went very blurry/could not see anything in front, right ear was affected, underwater like, blood pressure 79/50 and again 70/48, splotchy almost. Black and white and felt dizzy was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
he has thrombosis in leg; This is a spontaneous report received from a Pfizer sponsored program. A contactable consumer (patient himself) reported that a male patient of an unspecified age received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunisation. Medical history included metastatic cancer in the lungs (he's taking chemotherapy) and heart problems from an unknown date. The patient's concomitant medications were not reported. The patient was due the next day for the 2nd dose of the Pfizer vaccine. He was asking if he can take his pre-scheduled medication, especially he's taking chemotherapy because he has metastatic cancer in the lungs. Due also to the nature of him having heart problems, he had thrombosis in leg and he's taking blood thinner since an unspecified date. He was asking if he should stop the medication or if he can take the blood thinner before the 2nd dose. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Patient complained of right sided throat swelling that started 15 minutes after receiving vaccination. She also reported dizziness and nausea. She denies rash, hives, shortness of breath, tongue swelling, lip swelling, and any other symptoms. Patient received 50mg of Benadryl and 50mg of Solu Medrol upon arrival to ED which improved her symptoms.
multiple patients were vaccinated with improperly stored VARIVAX; No adverse effect; This spontaneous report was received from a medical assistant referred to a patient of an unknown age and gender. The patient's medical history and concomitant medications were not reported. On 04-DEC-2018, the patient was vaccinated with 1 dose of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX)(lot # R017642 and expiry date 20-JUN-2020) for prophylaxis and no adverse effects were reported (product storage error and no adverse event). Other suspect therapies included sterile diluent. There was a previous temperature excursion and the time frame and temperature was unknown. No PQC found.  This is one of several reports received from the same reporter.
This spontaneous report as received from a male patient refers to himself. On an unknown date the patient was vaccinated with ZOSTAVAX. On an unknown date the patient experienced pain, swelling and redness at the injection site. The outcome of all the events were not recovered. Additional information is not expected.
Presented to the pharmacy for his Pfizer covid-19 booster and a flu vaccine.  Both the Pfizer Covid-19 booster and flu vaccine were administered by our vaccinator.  After administration of the vaccine, the vaccinator felt that  looked younger than 18 years old and upon investigation it was determined that was only 17 years old.  The Pfizer covid-19 booster is only approved for 18 years and older.
diarrhea, chills, headache, myalgias for 3 weeks post vaccination
Caught Covid-19 after vaccination; "Greater than 35 days between doses of Moderna Covid-19 vaccine"; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Caught Covid-19 after vaccination) and PRODUCT DOSE OMISSION ISSUE ("Greater than 35 days between doses of Moderna Covid-19 vaccine") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE ("Greater than 35 days between doses of Moderna Covid-19 vaccine"). On 13-Jan-2021, the patient experienced COVID-19 (Caught Covid-19 after vaccination). At the time of the report, COVID-19 (Caught Covid-19 after vaccination) outcome was unknown and PRODUCT DOSE OMISSION ISSUE ("Greater than 35 days between doses of Moderna Covid-19 vaccine") had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment medication were reported. No treatment medications were provided.
PATIENT COMPLAINED OF APPREHENSION WITH VACCINATION. 3:04 BP 160/80, HR 96, RR 16 3:14 BP 140/70, HR 68, RR 20 3:33 BP 130/70, HR 80, RR 20 4PM LEFT SITE IN STABLE CONDITION
Patient got immunization in left arm and next day his arm and hand have felt tingling/numb but getting better throughout day.
received an expired dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received an expired dose) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received an expired dose). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (received an expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment information was provided. The vial was expired on 24-Oct-2021.
10/6/22 pt to hospital from SNF with fever and in respiratory distress; presented on NRB; had to be placed on FMR; found to be positive for COVID; given ABX and vitamins; not a candidate for Remdesivir or Baricitinib; DNR; A Fibrillation with RVR and hypotension; pt passed away in the hospital
Near syncope,  evaluated by EMS -dizzy, lightheaded. BP 128/72.  Monitored for 30 minutes, symptoms resolved.  Discharged home at 1:30 pm.
Was 9 weeks and 1 day pregnant when I received this vaccination. At 10 weeks and 1 day pregnant, a routine ultrasound showed the baby stopped growing at 9 weeks and 1 day (I had experienced a missed miscarriage). Due date was July 11 2018. Baby measured 2.5 cm to determine 9w1d death.
Moderately severe pain which made basic movements difficult and woke me up frequently throughout the night beginning evening of vaccination on 1/14/2021 and steadily worsening through the next day and night. Large oblong welt about 2 inches across at injection site. Symptoms started within a few hours of getting the injection and became steadily very significant by the next day. It took about 7 days to recover from the most significant symptoms and was still recovering from mild bruise and occasional itching but no redness. Today (1/26/2021) my arm started itching again, and I see that I have a large flat circular (about 2 inches across) red spot right where I had the welt a week ago.
Raised, red rash on arms and abdomen. Noticed within 24 hours of administration.
Severe headache; Hot flashes; Chills; Loss of appetite; Fatigue & exhaustion; Dulled sense of smell and taste; dulled sense of smell and taste; This is a spontaneous report from a non-contactable other hcp. A 31-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 24Feb2021 (Batch/Lot Number: EL3247) as 2ND DOSE, SINGLE for covid-19 immunisation. The medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 for covid-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. On 25Feb2021 05:00, the patient experienced severe headache, hot flashes, chills, loss of appetite, fatigue & exhaustion, dulled sense of smell and taste, and with onset 15 hours after shot administered adverse effects duration 48 hours; dulled sense of smell and taste still on-going dulled sense of smell and taste. The outcome of the events was reported as recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Pt recvd vax & broke out w/rash on face & arms & was scratching as soon as left the clinic; rash noted to face & arms-face sl swollen; sl wheezing; seen in ER;
Vaccine administered on 10/25/2013. On 10/26/2013, patient reports that his Right Arm was numb and sore. Also reports experiencing a fever with uncontrollable shaking the previous evening.
ModModerna COVID?19 Vaccine EUA?  Large Oval bumpy red Rash occurred at the injection site, 8 days after receiving the vaccine.  Itchiness, tenderness, hot to the touch.  Still apparent on Day 9 after injection, red, hot, bumpy and tender.  Same size.
BLOOD CLOTS; This spontaneous report received from a consumer via a company representative concerned a multiple female patient who was in their 40's (5 decades) of unknown race and ethnicity. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number were not reported and expiry: Unknown) dose, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the reporter reports of "women in their 40's experienced blood clots after vaccination". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clots was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210940304-Covid-19 vaccine ad26.cov2.s-Blood Clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
-Fainting  - Heavy breathing  - Irregular heartbeat - Fever  These symptoms lasted about 24 hours and were similar the one she experienced with previous pfizer covid-19 vaccination in 2021
Painful, hard, red swollen lump at injection site. Began hours after vaccination and continues to grow, now at 1.5" in diameter.
nausea; motion sickness; I wake up in the middle of the night (1-3x week); This spontaneous case was reported by a patient and describes the occurrence of MOTION SICKNESS (motion sickness), SLEEP DISORDER (I wake up in the middle of the night (1-3x week)) and NAUSEA (nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOTION SICKNESS (motion sickness), SLEEP DISORDER (I wake up in the middle of the night (1-3x week)) and NAUSEA (nausea). At the time of the report, MOTION SICKNESS (motion sickness), SLEEP DISORDER (I wake up in the middle of the night (1-3x week)) and NAUSEA (nausea) outcome was unknown.            No treatment and concomitant medication were not included.
Left arm swelling on 4/24/04. area (left deltoid) was red, hot, tender to touch. Neck was achy. Every day reddened area became larger. On 4/30/04 red area on deltoid was greater than 3 inches across. Tongue swelled  - had a yellow colored covering on tongue. Went to see MD. Dr. Prescribed Keflex, Bextra and Motrin. Diagnosis - reaction to vaccine cellulitis. Area was also blister like.
No adverse event; reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022) and NO ADVERSE EVENT (No adverse event) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M21A, 32030BD, EN6203 and EN6198) for COVID-19 prophylaxis.     Acute illness at the time of vaccination, chronic illness or if patient has ever been diagnosed with COVID-19 was unknown.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022).    No concomitant product reported by reporter.  Pharmacy staff reported that they inadvertently administered 51 doses of the monovalent vaccines. Lot number 004M21A, expiration date 13Jul2022 Date(s) of administration of vaccine were 26Jul2022 (40 doses), 04Aug2022 (1 dose), 19Aug2022 (1 dose), 30Sep2022 (1 dose). No treatment medication was reported.   This case was linked to MODERNATX, INC.-MOD-2023-704260 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2023: Significant follow up received. Route of administration for 4th vaccine and narrative was updated.; Sender's Comments:  MODERNATX, INC.-MOD-2023-704260:(Master case)
fever which continued overnight rising to 104F this morning.; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (fever which continued overnight rising to 104F this morning.) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced PYREXIA (fever which continued overnight rising to 104F this morning.). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (fever which continued overnight rising to 104F this morning.) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103 (High) 103F and 104 (High) 104F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Reporter stated that the fever improved for 1-2 hours after the patient took Tylenol but again returned to 103-104 F.   This case was linked to US-MODERNATX, INC.-MOD-2021-092506 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-092506:Same reporter
Pt recvd 1st & 2nd doses of ukn "Heptavax".3rd dose was Engerix-B. Pt did not devel hep B antibodies. 4th dose given 20NOV90 & pt "still does not have antibodies."
This spontaneous report was received from a retired nurse referring to herself of unknown age. Information about pertinent medical history, concurrent conditions, concomitant medication and drug reactions/allergies was not provided. On an unknown date "years ago", the patient was vaccinated with PNEUMOVAX 23 (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis. On an unknown date "a few years ago", the patient developed breast cancer. When patient started therapy could not be confirmed to be after she developed breast cancer. The outcome of breast cancer was unknown. The causality between PNEUMOVAX 23 and breast cancer was not provided. Upon internal review, breast cancer was determined to be medically significant.
Information has been received from a physician and a school nurse concerning a 10 year old female who on 06-NOV-1995 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was also noted that the child was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) on 21-SEP-1995 and 28-SEP-1998. A school nurse reported to the physician that between 24-MAR-2005 and 09-MAY-2005, the child developed a "more severe case" of chickenpox, noted to be breakthrough with 50 to 250 lesions. Unspecified medical attention was sought. The outcome is recovered. A product quality complaint was not involved. No additional information is expected.
PT received pneumovax in Left bicep on 13 Nov.  Reported to ER 14 Nov w/ Left bicep swelling and redness distal to injection site.  Given ancef IV and d/c to home on Keflex x 10 days
Fever, chills, body aches, fatigue, nausea, vomiting, headache Began around 5 am this morning and continuing now as of 2 pm 1000 mg acetaminophen taken twice
Patient woke up and asked me to look at her leg. An enlarged lymph node at the growing of her right leg was observed. A red, itchy rash had also appeared at the thigh injection site on the same leg. A fever of 100.4 developed later on in the afternoon, along with a head ache and light sensitivity. The following day, 11/23/14, pain in the stomach/ spleen area developed. On 11/25/14 a light, slightly raised rash was observed at 7:30 PM, covering patient's back and trunk. A nurse at her clinic was spoken with regarding these latest symptoms.
Patient was administered a Moderna Spikevax 11/14/2023 and it was later discovered that patient had had a Pfizer vaccine 09/28/23 at a Pharmacy.  No adverse effects have been reported to this point.
Within days, after my first dose, I started having really bad pain in my hands and thumb area with a lot of weakness. I went to an orthopedic doctor and he diagnosed me with arthritis and gave some medication and a topical cream. He also gave me a hand splints. Plus he gave me a steroid shot in my wrist area. It came back after my second dose as well. It started to go away and I got my 3rd shot and it came back with a vengeance. I am still dealing with this at this time.
10 x 10cm area induration and erythema on left anterior thigh. Non-tender. No fever or systemic symptoms. Slight limp.
Rash in raised area around where injection was administered.   It itches.  It is tender and a little painful.  When I do an online search, it matches the description I found for something referred to as "COVID arm". The vaccine description I was given to use in this box in reference to side effects due to the vaccine is "Moderna COVID-19 Vaccine EUA".
I got what the media calls ?Covid arm? one week after getting my injection. I?m experiencing swelling, hardness in the injection spot, and itchiness. There is about a quarter size red mark in the area as well. All my symptoms are mild and don?t interfere with my day to day, but I?d like to report the delayed reaction.
due to miscommunication, pt received  1 dose of the  Pfizer covid vaccine  instead the shingle shot the requested.  at the time of the incidence, pt already received both doses of Moderna covid vaccine
Received vaccines on afternoon of July 21, 2008.  States around 3:00 AM, Tuesday morning, July 22, 2008 her right arm began to itch. She scratched the area and the arm became red, hot, swollen, and itchy, along with a small bruise.  She utilized a cool cloth and ibuprofen.  Symptoms contined through Thursday, July 24 when she returned for PPD reading and presented the site to staff.  At July 24 visit, she stated the itching was spreading out further on her arm.  On evaluation, the site was warm and tender to touch.  Follow up call placed to client on July 25.  She had gone to a physician on July 24 for a school physical.  While at the physical appointment, she had the physician evaluate the arm.  Was instructed to take an "allergy medicine" around the clock, which she has done.  She states her arm is much better today. Although was evaluated by physician, the visit was not prompted by the reaction. Diluent for MMR and Varicella:  Lot # 5000X, expiration date:  May 2010.